Dld Asset Management, LP Aldeyra Therapeutics, Inc. Put Options Transaction History

Dld Asset Management, LP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 13, 2022	SELL	$3.25 - $5.17 $812,500 - $1.29 Million	-250,000 Closed	0 $0
Q4 2021 Feb 22, 2022	SELL	$3.5 - $9.63 $86.6 Million - $238 Million	-24,750,000 Reduced 99.0%	250,000 $1 Million
Q4 2021 Feb 14, 2022	BUY	$3.5 - $9.63 $87.5 Million - $241 Million	25,000,000 New	25,000,000 $1 Million
Q2 2019 Aug 14, 2019	SELL	$6.0 - $9.0 $703,800 - $1.06 Million	-117,300 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$7.14 - $9.85 $837,522 - $1.16 Million	117,300 New	117,300 $1.06 Million

117

36.4M

196K

142K

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $283M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

Get notified when there are updates to the investment portfolio of Dld Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Dld Asset Management, LP with notifications on news.